SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is drawing attention after a recent rebound that traders say held its gains, with bullish technical setups and positioning ahead of earnings. The upbeat view contrasts with concerns that high rates and a sluggish housing market could continue to weigh on renovation demand.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers sharp rally to fresh multi-year highs is drawing attention, with traders citing rotation into defensive, dividend-paying pharma stocks and positioning ahead of the quarterly report. Bulls see a technical breakout and pipeline momentum, while skeptics warn the move may meet resistance and point to patent-expiration and growth concerns.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 77,397.34014094 USD and is up 0.28 over the last 24 hours. It is currently trading on 12773 active market(s) with $12,152,377,915.37 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoin is drawing attention amid concerns over Binances reported major hack and paused withdrawals, with traders debating whether damaged exchange trust could trigger further selling. Others argue the market is absorbing the shock and point to Binances reported reimbursement progress and planned withdrawal reopening as reasons for optimism.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Attention centers on expected Q3 results and the Phase 3 QUILT-2.005 topline for ANKTIVA plus BCG in BCG-naive bladder cancer; the trial is database-locked, with a supplemental filing planned if results support it. Bullish traders see the readout and ANKTIVAs expanded bladder-cancer label as growth catalysts, while others question commercial uptake and point to competition, short-selling, and broader market weakness to explain the volatility.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders use the leveraged inverse Nasdaq ETF to hedge or bet on further weakness in tech, citing concerns about AI spending and valuations alongside recent tech-led selling. The community is divided: some expect more downside, while others warn that rumors of a U.S.Iran deal and a possible market rebound could reverse gains in the short ETF.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow is being discussed amid volatile, uneven trading across major indexes, with traders watching Fed policy and rising Treasury yields as pressures on equities. Some see relative strength in the Dow as money rotates away from tech, while others warn that inflation, oil-market risks and weakening momentum could deepen a selloff.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Discussion centers on BioCrysts upcoming quarterly results and whether continued ORLADEYO growth can support the stock despite its weak performance. Traders are also looking ahead to Navenibart and Netherton data, while debating managements acquisition strategy and expressing frustration over dilution and limited shareholder returns; buyout talk remains speculative.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results and outlook are drawing attention, with traders highlighting stronger streaming profitability and resilient theme-park performance. The reaction is mixed: some see support for a turnaround, while others point to the stocks persistent range-bound price action and difficulty holding gains.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention ahead of its upcoming earnings report, with traders watching whether guidance holds and how management addresses pressure on the pharmacy benefit management business. Some see the recent pullback as a potential technical rebound setup, while others remain cautious after the stocks recent selling.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

A sharp volatility spike has lifted UVIX, drawing traders seeking a hedge against a broader market pullback. The community is split between expecting volatility to persistciting concerns about oil, interest rates and geopolitical risksand warning that UVIX can quickly lose value as volatility fades and its leveraged futures exposure decays.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bitcoin’s ‘Digital Silver’ Cousin Tops Retail Interest After Outperforming Major Tokens

Cryptocurrency

Litecoin became the top-trending ticker on Stocktwits despite trading lower alongside the broader market.

James Flynn Acquires 70,000 Shares of Lite Strategy (NASDAQ:LITS) Stock

Lite Strategy, Inc. (NASDAQ:LITS - Get Free Report) Director James Flynn bought 70,000 shares of Lite Strategy stock in a transaction dated Friday, December 19th. The stock was acquired at an average...

James Flynn Purchases 70,000 Shares of Lite Strategy (NASDAQ:LITS) Stock

Lite Strategy, Inc. (NASDAQ:LITS - Get Free Report) Director James Flynn acquired 70,000 shares of the company's stock in a transaction dated Friday, December 19th. The stock was acquired at an...

Lite Strategy (NASDAQ:LITS) Major Shareholder Alexander Schornstein Sells 690,611 Shares

Lite Strategy, Inc. (NASDAQ:LITS - Get Free Report) major shareholder Alexander Schornstein sold 690,611 shares of the business's stock in a transaction on Thursday, December 18th. The shares were...

Lite Strategy (NASDAQ:LITS) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen raised Lite Strategy from a "sell" rating to a "hold" rating in a research report on Sunday...

Wall Street Zen Downgrades Lite Strategy (NASDAQ:LITS) to Sell

Wall Street Zen lowered Lite Strategy from a "hold" rating to a "sell" rating in a research note on Saturday...

Lite Strategy, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.

Lite Strategy Inc.

Bearish Sentiment

<ul class="summary-bullets"><li>Litecoin’s price fell 1.7% in the last 24 hours to around $78.15 but the token still outperformed crypto majors such as Bitcoin and Ethereum.</li><li>Retail sentiment on Stocktwits around Litecoin was in ‘extremely bullish’ territory while major tokens saw ‘bearish’ sentiment over the past day.</li><li>According to Litecoin creator Charlie Lee, Litecoin complements Bitcoin – it doesn’t&nbsp;compete against it.</li></ul><p>Litecoin (LTC) caught retail attention on Monday night as the ‘digital silver’ token outperformed Bitcoin (BTC) and other major tokens amid the current crypto market downturn</p><p><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.coingecko.com/en/coins/litecoin">Litecoin’s price</a> fell 1.7% in the last 24 hours to around $78.15. On Stocktwits, it&nbsp;was the top trending ticker on Monday night. Platform data showed retail sentiment trending in ‘extremely bullish’ territory over the past day, up from ‘neutral’ a week ago. Chatter was at ‘high’ levels, up from ‘normal’ a week ago.</p><p>Meanwhile,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.coingecko.com/en/coins/bitcoin">Bitcoin’s price</a> fell 2.8% in the last 24 hours to around $87,300 and Ethereum (ETH) dropped 2.9% to $2,940. Even Ripple’s native token XRP (XRP) dropped 2% and Solana (SOL) shed 3% in the last 24 hours. Most had ‘bearish’ sentiment behind them, as per Stocktwits data.</p><h2 class="st-heading-2">What Are Retail Traders Thinking?</h2><p>One user said they expect a rotation from precious metals into crypto after the New Year, which they believe could support gains in Litecoin’s price.</p><p><stembedurl>https://www.stocktwits.com/RaisingGainz/message/640377456</stembedurl></p><p>Another user noted that Lester, Litecoin’s mascot, was originally created as a parody of Litecoin holders – and is now being used to celebrate its success.</p><p><stembedurl>https://www.stocktwits.com/R3JS/message/640377721</stembedurl></p><h2 class="st-heading-2">Charlie Lee Touts ‘Digital Silver’</h2><p>Litecoin creator Charlie Lee has consistently framed the asset as a complement to Bitcoin rather than a rival. In an&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=A2pxSY5ruNI">interview</a> last month with David Gokhshtein, Lee described Litecoin as “digital silver” alongside Bitcoin’s “digital gold,” pointing to its faster transaction speeds and lower fees for payments.</p><p>Lee, a former Google engineer also known as SatoshiLite, launched Litecoin 14 years ago. He argued that the network’s longevity and reliability remain underappreciated, even as newer tokens dominate market narratives.</p><h2 class="st-heading-2">Institutional Access Expands</h2><p>Lee has also pointed to rising institutional interest this year, such as the launch of a Litecoin treasury strategy company, Lite Strategy (<a href="https://stocktwits.com/symbol/LITS">LITS</a>), and the introduction of the first-ever Litecoin ETF by Canary Capital (<a href="https://stocktwits.com/symbol/LTCC">LTCC</a>).&nbsp;</p><p>Lee has described such vehicles as a useful entry point, while maintaining that Litecoin’s long-term value depends on direct usage rather than passive investment alone.</p><h2 class="st-heading-2">Privacy And Fungibility Remain Core Focus</h2><p>Litecoin has also expanded its technical capabilities with the addition of MimbleWimble Extension Block (MWEB), a privacy and fungibility layer announced in October earlier this year. Fungibility ensures each unit of Litecoin is treated equally, a property Lee has described as essential for sound money.</p><p>While privacy features add technical complexity, Lee has said they address financial safety and user rights rather than illicit activity. He has also noted that projects like Monero (XML) and Zcash (ZEC) have helped elevate broader awareness of privacy issues across the crypto market.</p><p>Litecoin’s price has fallen around 20% this year and remains 80% below its record high of over $410, seen four years ago. Traders will now be eyeing the launch of LitVM test scheduled to go live in the first quarter (Q1) of 2026.&nbsp; It is aimed at enabling developers to test EVM-compatible smart contracts and zero-knowledge rollups on Litecoin.</p><p><strong>Read also:&nbsp;</strong><a href="https://stocktwits.com/news-articles/markets/cryptocurrency/mstr-bmnr-stocks-slip-while-bitcoin-ethereum-post-weekend-gains/cL75LVVREDW"><strong>MSTR, BMNR, And Other Crypto-Linked Stocks Slip While Bitcoin, Ethereum Post Weekend Gains</strong></a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, a LiteCoin logo is displayed on a smartphone. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Lite Strategy, Inc.

Litecoin

Canary Litecoin ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.12
Prev Close	$1.17
Open	$1.17
Dividend Yield	0.00%
50-Day Moving Average	$1.17
Beta	1.04
Avg. Volume	921,909.41
PE Ratio	-0.56

52-Week High	$2.26
52-Week Low	$0.6888
Market Capitalization	$34.06M
EPS (Annual)	-$2.06
Price to Book	0.87
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

LITS Fundamentals